A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: The Cystadrops OCT-1 study
- 1 March 2014
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 111 (3) , 314-320
Abstract
No abstract availableKeywords
Funding Information
- Orphan Europe, Immeuble Le Wilson-70, avenue du Général de Gaulle 92800 Puteaux, France
This publication has 17 references indexed in Scilit:
- Gel formulations for treatment of the ophthalmic complications in cystinosisInternational Journal of Pharmaceutics, 2010
- Evaluation of Treatment With Cysteamine Eyedrops for Cystinosis With Confocal MicroscopyCornea, 2009
- Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosisEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- In vivo confocal microscopy and polarizing microscopy of the cornea in a patient with nephropathic cystinosisClinical & Experimental Ophthalmology, 2007
- Confocal microscopy of the cornea in nephropathic cystinosisBritish Journal of Ophthalmology, 2005
- CystinosisNew England Journal of Medicine, 2002
- Corneal Crystals in Nephropathic Cystinosis: Natural History and Treatment with Cysteamine EyedropsMolecular Genetics and Metabolism, 2000
- A Randomized Clinical Trial of Topical Cysteamine Disulfide (Cystamine) versus Free Thiol (Cysteamine) in the Treatment of Corneal Cystine Crystals in CystinosisMolecular Genetics and Metabolism, 1998
- A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosisEye, 1991
- Removal of Corneal Crystals by Topical Cysteamine in Nephropathic CystinosisNew England Journal of Medicine, 1987